Varenicline, marketed under the trade names Chantix® in the US and Champix® in Canada, is a smoking cessation drug used to treat nicotine addiction. Within the last two years, the US Food and Drug Administration (FDA) has issued safety warnings and announcements regarding potential adverse effects from depression and suicidal thoughts to increased risk of certain cardiovascular events.